FIRST TRUST NYSE ARCA BIOTEC (FBT) Stock News
NYSEARCA:FBT - NYSE Arca - US33733E2037 - ETF - Currency: USD
FBT Latest News, Press Relases and Analysis
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish
Genmab receives royalties on the worldwide net sales of Darzalex, both the intravenous and subcutaneous products, under J&J's exclusive worldwide license to develop, manufacture, and commercialize daratumumab.
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of the abortion pill mifepristone.
4 Top Biotech Stocks to Buy for 2022
The growing demand for efficient and viable drugs, vaccines, and treatments for curing chronic diseases and newly emerging coronavirus variants should accelerate the biotech industry’s growth over the long term. Thus, it might be wise to invest in undervalued biotech stocks Regeneron (REGN), Biogen (BIIB), United Therapeutics (UTHR), and Exelixis (EXEL) with immense potential.
Biotech ETFS: How To Pick Biotech Stock Winners And Avoid 2020 Volatility
Biotech ETFs allow investors to buy into a basket of biotech stocks, rather than trying to select specific winners. This eases up on volatility.
Top biotech analyst Schoenebaum dies
Bloomberg reports that Evercore ISI's Mark Schoenebaum, a highly regarded biotech analyst, has died from undisclosed causes.The 20-year veteran took a medical leave from Evercore in 2016. Three months
Top-Performing ETFs Of The 10-Year Bull-Run
The bull looked too tired at times and many experts predicted its demise with slowing global growth and rising trade tensions, but it has managed to survive so far. Many ETFs have crushed the broader indexes during this period.
10 Top-Ranked ETFs Leading The 10-Year Bull Run
Top-performing ETFs of the 10-year bull market that will continue to outperform in the coming months.
Is iShares Nasdaq Biotechnology Index Fund a Buy?
The largest biotech ETF looks good for investors who don't mind the industry's manic behavior.